Category
page 1Platinum(IV) compounds
platinum(IV) chloride
chemical compound
Adams' catalyst
chemical compound
ammonium chloroplatinate
chemical compound
disodium hexachloroplatinate
chemical compound
platinum(IV) bromide
chemical compound
satraplatin
Satraplatin (INN, codenamed JM216) is a platinum-based antineoplastic agent that was under investigation as a treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues—cisplatin, carboplatin, and oxaliplatin—must be given intravenously.
platinum tetrafluoride
chemical compound
platinum disulfide
chemical compound
platinum(IV) iodide
chemical compound
platinum diselenide
chemical compound
platinum silicide
chemical compound
Rhodium-platinum oxide
chemical compound
hexachloroplatinate
Hexachloroplatinate is an anion with the chemical formula [PtCl6]2−.